Parkin

Alternative Names

  • PARK2
  • PRKN
  • Fragile Site FRA6E
Back to search Result
OMIM Number

602544

NCBI Gene ID

5071

Uniprot ID

O60260

Length

1,380,386 bases

No. of Exons

14

No. of isoforms

8

Protein Name

E3 ubiquitin-protein ligase parkin

Molecular Mass

51641 Da

Amino Acid Count

465

Genomic Location

chr6:161,347,416-162,727,801

Gene Map Locus
6q26

Description

The precise function of this gene is unknown; however, the encoded protein is a component of a multiprotein E3 ubiquitin ligase complex that mediates the targeting of substrate proteins for proteasomal degradation. Mutations in this gene are known to cause Parkinson disease and autosomal recessive juvenile Parkinson disease. Alternative splicing of this gene produces multiple transcript variants encoding distinct isoforms. Additional splice variants of this gene have been described but currently lack transcript support. [From RefSeq]

Epidemiology in the Arab World

View Map
Variant NameCountryGenomic LocationClinvar Clinical SignificanceCTGA Clinical Significance Condition(s)HGVS ExpressionsdbSNPClinvar
NM_004562.2:c.601_602insALebanon; United Arab E...NC_000006.12:g.162054107_162054108insTLikely PathogenicParkinson Disease 2, Autosomal Recessive JuvenileNG_008289.1:g.678695_678696insA; NM_004562.2:c.601_602insA; NP_004553.2:p.Cys201Ter1231455463

Other Reports

Algeria

To determine the frequency of deletions in the PARK2 gene, Lucking et al. (1998) searched for homozygous deletions in the PARK2 gene in 12 PARK2-linked families with autosomal recessive juvenile Parkinsonism and known or suspected consanguinity (a total of 32 patients). Five of the families originated from Italy, four from France, one from the Netherlands, one from Portugal, and one from Algeria. Six of the families had previously been reported by Tassin et al. (1998). They found two novel homozygous deletions in eight patients from three families. The Algerian family carried a deletion of exons 8 and 9. Mean age at onset and clinical severity were similar in the deleted and nondeleted families. The overall clinical features were also similar with a significantly later mean age at onset than those with exon 8-9 deletions, and a trend toward greater severity for similar disease durations. The association of the exon 8-9 deletion with earlier age at onset is suggestive that the less truncated protein resulted in an additional toxic effect.

Jordan

Myhre et al. (2008) investigated 11 consanguineous families with 17 affected members with recessively inherited young-onset Parkinsonism for mutations both in the parkin and PINK1 genes. In the parkin gene, a three-generation family was identified with an exon 4 deletion segregating with the disease. Both affected members were homozygous for the deletion that segregated on one haplotype that spanned the gene. Exon dosage analysis confirmed the recessive pattern of inheritance with heterozygous deletions segregating in healthy family members.

Tunisia

Gouider-Khouja et al. (2003) identified the genetic findings in three siblings with autosomal recessive- juvenile Parkinsonism (AR-JP) by performing a genetic linkage analysis with markers spanning the Parkin gene locus. Genotyping was determined by PCR using nine nucleotide polymorphic primers. Haplotype analysis showed homozygosity of affected individuals for three markers (D6S1550, D6S411, and D6S1599) suggesting linkage to the Park 2 locus. A recombination was observed for the fourth intragenic marker D6S305. Sequencing of the Parkin gene revealed a two-base homozygous deletion (AG) within exon 2, which allowed to classify Parkinsonism in that family as AR-JP.

© CAGS 2024. All rights reserved.